G Shrikhande
Overview
Explore the profile of G Shrikhande including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marone A, Hoi J, Khalil M, Kim H, Shrikhande G, Dayal R, et al.
Biomed Opt Express
. 2019 Feb;
10(2):657-669.
PMID: 30800506
To simulate the hemodynamic effects in the feet in response to a thigh cuff occlusion, we have developed a multi-compartmental model in which the circulatory system for the leg is...
2.
Khalil M, Kim H, Hoi J, Kim I, Dayal R, Shrikhande G, et al.
Eur J Vasc Endovasc Surg
. 2014 Dec;
49(1):83-9.
PMID: 25457299
Objective: Vascular optical tomographic imaging (VOTI) is a novel imaging modality that is capable of detecting hemoglobin concentrations in tissue. VOTI is non-invasive, non-ionizing and does not require contrast injection....
3.
Sattler M, Verma S, Shrikhande G, Byrne C, Pride Y, Winkler T, et al.
J Biol Chem
. 2000 Jun;
275(32):24273-8.
PMID: 10833515
The BCR/ABL oncogene causes chronic myelogenous leukemia, a myeloproliferative disorder characterized by clonal expansion of hematopoietic progenitor cells and myeloid cells. It is shown here that transformation of the hematopoietic...
4.
Sattler M, Verma S, Byrne C, Shrikhande G, Winkler T, Algate P, et al.
Mol Cell Biol
. 1999 Oct;
19(11):7473-80.
PMID: 10523635
The BCR/ABL oncogene causes chronic myelogenous leukemia (CML), a myeloproliferative disorder characterized by clonal expansion of hematopoietic progenitor cells and granulocyte lineage cells. The SH2-containing inositol-5-phosphatase SHIP is a 145-kDa...
5.
Sattler M, Winkler T, Verma S, Byrne C, Shrikhande G, Salgia R, et al.
Blood
. 1999 Apr;
93(9):2928-35.
PMID: 10216087
Hematopoietic growth factors (HGFs) stimulate growth, differentiation, and prevent apoptosis of progenitor cells. Each growth factor has a specific cell surface receptor, which activates both unique and shared signal transduction...
6.
Sattler M, Salgia R, Shrikhande G, Verma S, Choi J, Rohrschneider L, et al.
Oncogene
. 1997 Dec;
15(19):2379-84.
PMID: 9393882
We report here that interleukin-3 (IL-3) and erythropoietin (EPO) induce formation of a complex composed of two SH2-containing phosphatases, the tyrosine phosphatase SHP-2 and the SH2 containing inositol 5-phosphatase (SHIP)....
7.
Sattler M, Salgia R, Shrikhande G, Verma S, Uemura N, Law S, et al.
J Biol Chem
. 1997 May;
272(22):14320-6.
PMID: 9162067
CRKL is an SH2-SH3-SH3 adapter protein that is a major substrate of the BCR/ABL oncogene. The function of CRKL in normal cells is unknown. In cells transformed by BCR/ABL we...
8.
Sattler M, Salgia R, Shrikhande G, Verma S, Pisick E, Prasad K, et al.
J Biol Chem
. 1997 Apr;
272(15):10248-53.
PMID: 9092574
Steel factor (SF) is a growth and survival factor for hematopoietic cells. The receptor for SF, c-Kit, contains intrinsic tyrosine kinase activity, and binding of SF induces rapid tyrosine phosphorylation...